articleTop 1% cited
A phase II study
European Journal of Cancer · 2000 · Vol. 36(8) · pp. 1016–1025
Philippe Rougier✉(Institut Gustave Roussy)Antoine Adenis(Centre Oscar Lambret)Michel Ducreux(Institut Gustave Roussy)M Forni(Institut Gustave Roussy)J. Bonneterre(Centre Oscar Lambret)M. DembakP. ClouetAnne LebecqP. BailleF Lefresne-SoulasC. BlancJean‐Pierre Armand(Institut Gustave Roussy)
Cancer Treatment and PharmacologyPancreatic and Hepatic Oncology ResearchColorectal Cancer Treatments and StudiesDocetaxelMedicineAdverse effectInternal medicinePremedicationPharmacokineticsIncidence (geometry)ChemotherapySurgery
MeSH terms
DocetaxelAdenocarcinomaAdolescentAdultAgedAntineoplastic AgentsFemaleFranceHematologic DiseasesHumansMaleMiddle AgedNeoplasm MetastasisPancreatic NeoplasmsSurvival Analysis
Funding
- University of Texas MD Anderson Cancer Center
Citations
752
FWCI
25.28
field-weighted impact
References
58
Percentile
100%
vs. same field & year
Citations per year
Cited by
Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production
Nature Medicine · 2008 · 2,331 citations
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
Hepatology · 2002 · 2,609 citations
References
Cancer: Principles and Practice of Oncology.
Annals of Internal Medicine · 1991 · 8,541 citations
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
Journal of Clinical Oncology · 1997 · 5,865 citations
Mechanism of action of taxol
Trends in Pharmacological Sciences · 1992 · 732 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.